66 results match your criteria: "the 302 Hospital[Affiliation]"

[Transcriptional inhibitory effect of hepatitis B virus X protein on the expression of p53 tumor suppression gene].

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi

March 2006

Viral Hepatitis Research Center, Institute of Infectious Diseases, The 302 Hospital of The People's Liberation Army, Beijing 100039, China.

Background: To investigate the transcriptional inhibitory role of hepatitis B virus X protein on the expression of p53 tumor suppression gene.

Methods: The promoter sequence of the p53 tumor suppression gene was identified and amplified by bioinformatics and polymerase chain reaction (PCR). The recombinant reporter gene expression vector pCAT3-p53p was constructed and transfected into the hepatoblastoma cell line HepG2 and cotransfected with pcDNA3.

View Article and Find Full Text PDF

Objective: To study and analyze the antibacterial effects of different extracts from Radix Isatis.

Methods: Staphylococcus aureus was used as the studied object in the experiment. Antibacterial effects of extracts from Radix Isatis were observed by thermocalrimetry on Staphylococcus aureus, together with common pharmacological experiments.

View Article and Find Full Text PDF

Cloning and characterization of a novel hepatitis B virus core binding protein C12.

World J Gastroenterol

September 2005

Gene Therapy Research Center, Institute of Infectious Diseases, The 302 Hospital of PLA, 100 Xisihuanzhong Road, Beijing 100039, China.

Aim: To elucidate the biological function of HBV core antigen (HBcAg) on pathogenesis of hepatitis B, a novel gene C12 coding for protein with unknown function interacting with HBcAg in hepatocytes was identified and characterized.

Methods: HBcAg bait plasmid pGBKT7-HBcAg was constructed and transformed into yeast AH109, then the transformed yeast was mated with yeast Y187 containing liver complementary DNA (cDNA) library plasmid in 2XYPDA medium. Diploid yeast was plated on synthetic dropout nutrient medium (SD/-Trp-Leu-His-Ade) and synthetic dropout nutrient medium (SD/-Trp-Leu-His-Ade) containing X-alpha-gal for screening twice.

View Article and Find Full Text PDF

Aim: To investigate the transactivating effect of pre-S2 protein of hepatitis B virus (HBV) and construct a subtractive cDNA library of genes transactivated by pre-S2 protein with suppression subtractive hybridization (SSH) technique, and to pave the way for elucidating the pathogenesis of HBV infection.

Methods: pcDNA3.1(-)-pre-S2 containing pre-S2 region of HBV genome was constructed by routine molecular methods.

View Article and Find Full Text PDF

We used one day old Beijing ducklings infected by duck hepatitis B virus as experimental model to observe anti-virus effect of HSS. Beijing ducklings hatched within one day were injected intravenously with duck hepatitis B virus (DHBV). Positive DHBV-DNA in ducklings' sera were detected 7 days later.

View Article and Find Full Text PDF

Objective: To compare the inhibitory effects of cytokine-induced killer (CIK) cells alone, chemotherapeutic drug alone, and CIK cells combined with chemotherapeutic drug on the growth of hepatocellular carcinoma (HCC) cells transplanted in nude mice.

Methods: Peripheral blood mononuclear cells (PBMC) collected from five healthy donors by blood cell separator were incubated in vitro to induce CIK cells in the presence of interferon-gamma (IFN-gamma), IL-2 and anti-CD3 monoclonal antibody (mAb). The phenotype of CIK cells was characterized by flow cytometric analysis.

View Article and Find Full Text PDF

[Diversity of clinical manifestation of chronic hepatitis C].

Zhonghua Gan Zang Bing Za Zhi

February 2004

Gene Therapy Research Center, Institute of Infectious Disease, the 302 Hospital of PLA, Beijing 100039, China.

View Article and Find Full Text PDF

Objective: To investigate the alteration of the cellular profiles of T lymphocyte subsets and dendritic cell subsets in peripheral blood of primary hepatocellular carcinoma (HCC) patients after being transfused with autologous cytokine-induced killer cells (CIK) in patients, then to evaluate the clinical efficacy of the immune therapeutic strategy.

Methods: Peripheral blood mononuclear cells (PBMCs) from 13 patients with primary were collected using blood cell separator, and expanded in the fresh AIM-V medium in the presence of cytokine cocktail including interferon-gamma (IFN-gamma), monoclonal antibody (mAb) against CD3 and interleukin-2 (IL-2). The phenotypic patterns of CIK cells were longitudinally characterized by flow cytometry on day 0, 4, 7, 10,13 and 15 during the incubation period.

View Article and Find Full Text PDF

Objective: To search for genomic DNA sequence of the augmenter of liver regeneration (ALR) of rat.

Methods: Polymerase chain reaction (PCR) with specific primers was used to amplify the sequence from the rat genome.

Results: A piece of genomic DNA sequence and a piece of pseudogene of rat ALR were identified.

View Article and Find Full Text PDF

Aim: To investigate the interaction between hepatitis C virus core protein and translin protein and its role in the pathogenensis of hepatocellular carcinoma and lymphoma.

Methods: With the components of the yeast two hybrid system 3, "bait" plasmids of HCV core the gene was constructed. After proving that hepatitis C virus core protein could be firmly expressed in AH109 yeast strains, yeast two- hybrid screening was performed by mating AH109 with Y187 that transformed with liver cDNA library plasmids-pACT2 and then plated on quadruple dropout (QDO) medium and then assayed for alpha-gal activity.

View Article and Find Full Text PDF

Aim: This study investigated the anti-cancer effect of combined quercetin and a recombinant adenovirus vector expressing the human p53, GM-CSF and B7-1 genes (designated BB-102) on human hepatocellular carcinoma (HCC) cell lines in vitro.

Methods: The sensitivity of HCC cells to anticancer agents was evaluated by 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The viability of cells infected with BB-102 was determined by trypan blue exclusion.

View Article and Find Full Text PDF

Molecular mechanisms of hepatitis virus-hepatocyte interactions.

J Gastroenterol Hepatol

December 2002

Gene Therapy Research Center, Institute of Infectious Diseases, The 302 Hospital of PLA, Beijing, China.

View Article and Find Full Text PDF

[A preliminary study on the heterogeneity of preS2 region in hepatitis B virus].

Zhonghua Nei Ke Za Zhi

April 2002

Gene Therapy Research Center, Institute of Infectious Diseases, The 302 Hospital of PLA, Beijing 100039, China.

Objective: To investigate the mutation of the preS2 gene sequence of HBV and clarify the significance of HBV quasispecies groups in the patients with chronic HBV infection.

Methods: A set of specific primers were synthesized according to HBV DNA sequence of a Chinese strain. The preS2 gene region was amplified by PCR method from the sera of 51 patients with chronic HBV infection, and the PCR products from 5 patients were subcloned into pGEM Teasy vectors.

View Article and Find Full Text PDF

[The study on heterogeneity of hepatitis B virus DNA].

Zhonghua Yi Xue Za Zhi

January 2002

Gene Therapy Research Center, Institute of Infectious Diseases, The 302 Hospital of PLA, Beijing 100039, China.

Objective: To investigate the HBV quasispecies groups in the patients with chronic HBV infection.

Methods: Specific primers ware synthesized according to HBV strain found in China, the preC/C gene, reverse transcriptase region, whole S region, X gene and whole genome ware amplified by PCR method from the serum of 18 patients with chronic HBV infection, and then the PCR products were subcloned into pGEM Teasy vectors. Positive clones with target sequences were selected out for sequencing.

View Article and Find Full Text PDF

Objective: To study the expression of P21 and P15 proteins in liver tissue of chronic viral hepatitis (CH) and hepatocellular carcinoma (HCC) and their relation to cell apoptosis.

Methods: The expression of P21 and P15 proteins in 36 CH patients liver tissues were detected by immunohistochemistry and the DNA damage of the hepatocytes were detected by TDT mediated dUDT nick and labeling (TUNEL). 10 cases of HCC were also studied.

View Article and Find Full Text PDF

[Cloning and sequence analysis of human genomic DNA of augmenter of liver regeneration hepatitis].

Zhonghua Gan Zang Bing Za Zhi

February 2000

Gene Therapy Research Center, Institute of Infectious Diseases, the 302 Hospital of PLA, Beijing 100039, China.

Objective: To clone the human genomic DNA of augmenter of liver regeneration (ALR) and specify the intron-exon structure.

Methods: Using human ALR cDNA sequence as a reference and BLAST path as a nucleotide homology search tool, GenBank has been searched for ALR homologous genomic DNA sequence. The intron-exon sequences were defined by the Breathnath-Chambon rule.

View Article and Find Full Text PDF